All patients received chemotherapy.

These differences remained when the gross tumor volume was considered. Our goal is the best way to found to treat the cancer without further weakening the patient, said Ritsuko Komaki, about 114,000 MD Anderson Department of Radiation Oncology and lead author of the study. Standard care currently provides a 25 % five-year survival rate, but as a physician I have seen how the treatment of the patients affects the general health. Are they tired, suffering from night sweats, are more susceptible to infection and have to compromise their treatment. With proton therapy, we can now have the option to reduce this toxicity so that treatment dosage can be maximized. .. Researchers compared bone marrow toxicity levels in 142 patients for lung cancer between January 2003 and June 2008 treated.